BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15662579)

  • 1. [Prevention of diabetes mellitus type 1].
    Scherbaum WA; Hauner H
    Dtsch Med Wochenschr; 2005 Jan; 130(4):141-2. PubMed ID: 15662579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight control of type 1 diabetes: recommendations for patients.
    Havas S; Donner T
    Am Fam Physician; 2006 Sep; 74(6):971-8. PubMed ID: 17002031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing hypoglycemia in primary care.
    Tenzer-Iglesias P; Shannon MH
    J Fam Pract; 2012 Oct; 61(10 Suppl):S1-8. PubMed ID: 23106068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes in the young: what are their long term health prospects?
    Greene S
    Arch Dis Child; 2009 Apr; 94(4):251-3. PubMed ID: 19307199
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current aspects and future perspectives of pharmacotherapy or type II diabetes].
    Ben Salem C; Elouni B; Bouraoui K
    Tunis Med; 2004 Oct; 82(10):905-13. PubMed ID: 15686186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 diabetes mellitus: primary, secondary, and tertiary prevention.
    Bollyky J; Sanda S; Greenbaum CJ
    Mt Sinai J Med; 2008 Aug; 75(4):385-97. PubMed ID: 18729155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey on acute and chronic complications in children and adolescents with type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania.
    Majaliwa ES; Munubhi E; Ramaiya K; Mpembeni R; Sanyiwa A; Mohn A; Chiarelli F
    Diabetes Care; 2007 Sep; 30(9):2187-92. PubMed ID: 17563337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Kilpatrick ES; Rigby AS; Atkin SL
    Diabetes Care; 2006 Jul; 29(7):1486-90. PubMed ID: 16801566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    Viberti G
    J Diabetes Complications; 2005; 19(3):168-77. PubMed ID: 15866064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.
    Rossetti P; Porcellati F; Bolli GB; Fanelli CG
    Diabetes Care; 2008 Feb; 31 Suppl 2():S113-20. PubMed ID: 18227470
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased renal glucose metabolism in Type 1 diabetes mellitus.
    Meyer C; Tolias A; Platanisiotis D; Stumvoll M; Vlachos L; Mitrakou A
    Diabet Med; 2005 Apr; 22(4):453-9. PubMed ID: 15787672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlocking the opportunity of tight glycaemic control. Far from goal.
    Del Prato S
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of children and adolescents with diabetes mellitus: personal experience].
    Dorchy H
    Rev Med Brux; 2005 Sep; 26(4):S246-54. PubMed ID: 16240870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing insulin resistance in Type 1 diabetes.
    Pang TT; Narendran P
    Diabet Med; 2008 Sep; 25(9):1015-24. PubMed ID: 19183305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of stroke in patients with and without diabetes--similarity and differences].
    Zalisz M
    Pol Merkur Lekarski; 2007 Oct; 23(136):291-6. PubMed ID: 18293854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of type 1A diabetes: update.
    Vardi P; Koren I; Bloch K
    Isr Med Assoc J; 2004 May; 6(5):301-4. PubMed ID: 15151375
    [No Abstract]   [Full Text] [Related]  

  • 19. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.